Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 3, p. 771–787, 2023. DOI: 10.25251/skin.7.3.3. Disponível em: https://skin.dermsquared.com/skin/article/view/2140. Acesso em: 15 jun. 2025.